We have previously reported that a targeted anti-caries DNA vaccine, pGJA-P, induced accelerated and increased antibody responses compared with a non-targeted anti-caries DNA vaccine. Recently, pGJA-P/VAX, a new targeted anti-caries DNA vaccine for human trials, was constructed by replacing the pCI vector used in the construction of pGJA-P with pVAX1, the only vector authorized by the US Food and Drug Administration in clinical trials. Here, we report on our exploration of the kinetics of the antibody responses generated following pGJA-P/VAX immunization and the persistence of pGJA-P/VAX at both the inoculation site and the draining lymph nodes. Intranasal vaccination of mice with pGJA-P/VAX induced strong antibody responses that lasted for more than 6 months. Furthermore, pGJA-P/VAX could still be detected at both the inoculation site and the draining cervical lymph nodes 6 months after immunization. Thus, the persistent immune responses are likely due to the DNA depot in the host, which acts as a booster immunization.

译文

:我们以前曾报道过,与非靶向抗龋DNA疫苗相比,靶向抗龋DNA疫苗pGJA-P诱导了加速和增加的抗体反应。最近,通过用美国食品药品监督管理局(FDA)授权的唯一载体pVAX1替代了用于构建pGJA-P的pCI载体,构建了一种用于人类试验的新型靶向抗龋齿DNA疫苗pGJA-P / VAX。临床试验。在这里,我们报告了我们对pGJA-P / VAX免疫后产生的抗体反应动力学以及pGJA-P / VAX在接种部位和引流淋巴结处持续存在的探索。用pGJA-P / VAX对小鼠进行鼻内疫苗接种可产生持续超过6个月的强烈抗体反应。此外,免疫后6个月,在接种部位和宫颈引流淋巴结仍可检测到pGJA-P / VAX。因此,持久的免疫反应很可能是由于宿主中的DNA贮藏所引起的,而这种贮藏所起到了加强免疫的作用。

+1
+2
100研值 100研值 ¥99课程
检索文献一次
下载文献一次

去下载>

成功解锁2个技能,为你点赞

《SCI写作十大必备语法》
解决你的SCI语法难题!

技能熟练度+1

视频课《玩转文献检索》
让你成为检索达人!

恭喜完成新手挑战

手机微信扫一扫,添加好友领取

免费领《Endnote文献管理工具+教程》

微信扫码, 免费领取

手机登录

获取验证码
登录